Search results :

Fondaparinux

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: B01AX05

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Oedema uncommon, 8.66% - 8.8% x x x x x
Rash uncommon, 7.5% - 8.32% x x x x x x x x x
Anaemia uncommon — 0.272% - 19.6% 1.2% - 1.22% x x x x x x x x x
Gingival bleeding common x x
Insomnia 0.917% - 5.41% 0.304% x x x x x x x
Postoperative wound infection rare, 4.9% x x x x x x
Constipation rare, 1.8% - 10.5% 2.1% x x x x x
Wound discharge increased 0.612% - 4.65% 0% x x x x x x x
Hypokalaemia rare, 0% - 4.2% 0% x x x x x x x x x
Dizziness rare, 0.612% - 4.17% 0% x x x x x x x x x
Purpura uncommon, 0% - 3.54% 0% x x x x x x x x x
Urinary tract infection 1.82% - 4% 4% x x x
Nausea uncommon, 0.3% - 12.2% 1.2% x x x x x
Body temperature increased uncommon, 0.3% - 15.4% 1.2% - 4.44% x x x x x
Hypotension rare, 0.306% - 3.5% 0% x x x x x x x x x
Confusional state rare, 1.2% - 4.1% 0.3% - 0.304% x x x x x x x x x
Urinary retention 2.9% - 2.96% x x x
Haemoglobin decreased 1.89% - 3.86% x
Eruption 2.58% - 3.1% x
Haematuria uncommon, common x x
Haemoptysis uncommon, common x x
Haematoma uncommon — 1.2% - 2.85% 0.3% - 0.304% x x x x x x x x x
Bullous eruption 0% - 3.1% 0.304% x x x x x x
Dyspepsia rare, 2.4% - 2.58% x x x x x
Postoperative hemorrhage common, 0.6% - 2.4% 0.6% - 0.608% x x x x x x x x x
Alanine aminotransferase increased 0.305% - 4.27% x
Atrial fibrillation 1.03% - 3.02% 2.02% x
Headache rare, 1.43% - 4.53% 2.24% x x x x x
Diarrhoea rare, 0.5% - 2.58% 2.4% x x x x x
Pain 1.7% - 2.55% x x x
Contusion 1.05% - 2.18% x
Aspartate aminotransferase increased 0.174% - 2.82% x x x x x
Chest pain rare, 0.727% - 1.84% 1.49% x x x
Epistaxis uncommon, 1.09% - 1.31% x x x x x x x
Ventricular tachycardia 0.281% - 1.66% 1.03% x
Abdominal pain rare, 1.27% - 1.44% x x x
Vomiting uncommon, 0.501% - 5.97% 1.2% - 1.49% x x x x x
Back pain 0.999% - 1.31% x
Surgical site reaction 0.7% - 1.5% 2.4% x
Haemorrhage postmarketing — 0% - 5.02% 0% - 2.2% x x x x x x x x x
Leg pain rare, 0.908% - 1.35% x x x
Prothrombin level decreased 0.272% - 1.31% x
Anxiety rare, 0.727% - 0.785% x x x
Cough rare, 0.636% - 2.09% x x x
Surgical intervention 0.391% - 0.782% x
Coagulopathy uncommon x x
Pruritus uncommon x x x x x x x x x
Oedema peripheral uncommon x x
Hepatic function abnormal uncommon, 0.436% - 1.27% x x x
Hepatic enzyme increased uncommon, 0.305% - 4.72% x x x
Wound secretion uncommon x x
Thrombocytosis uncommon x x
Cardiac tamponade 0.35% - 0.543% 0.79% - 1.06% x
Dyspnoea rare, uncommon x x
Haemorrhage intracranial 0% - 0.131% x x x x x x x
Anaphylactic shock postmarketing, rare x x x x
Angioedema postmarketing, rare x x x x
Fatigue rare x x
Flushing rare x x
Gastritis rare x x
Hyperbilirubinaemia rare x x
Hypersensitivity postmarketing, rare x x x x x x
Syncope rare x x
Thrombocytopenia postmarketing, uncommon x x x x x x x x x
Thrombosis postmarketing x x x x
Vertigo rare x x
Oedema genital rare x x
Heparin-induced thrombocytopenia postmarketing x x x x
Hot flush rare x x
Spinal haematoma postmarketing x
Somnolence rare x x
Blister x x x x
Infection x x
Eye haemorrhage x
Gastrointestinal disorder x x
Cardiac arrest x
Cardiac failure x
Immune system disorder x x
Liver disorder x x x x x x
Mediastinal disorder x x
Nervous system disorder x x
Angiopathy x x
Injection site haemorrhage x x x x x x x
Retroperitoneal haemorrhage 0% x x x x x x x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x x
Hepatobiliary disease x x
Haemorrhagic stroke x
Drug interaction x
Infestation NOS x x
Blood and lymphatic system disorders x x
Local reaction x x x x x x
Acute coronary syndrome x
Catheter thrombosis x
Cerebral haemorrhage x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

FONDAPARINUX

Side effects:26
Source:FDA Structured Product Label

FONDAPARINUX

Side effects:29
Source:FDA Structured Product Label

FONDAPARINUX

Side effects:29
Source:FDA Structured Product Label

fondaparinux

Side effects:30
Source:FDA Structured Product Label

FONDAPARINUX SODIUM / ARIXTRA

Side effects:32
Source:FDA

Fondaparinux Sodium / Arixtra

Side effects:32
Source:FDA

FONDAPARINUX SODIUM / ARIXTRA

Side effects:56
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label